InvestorsHub Logo
Post# of 252582
Next 10
Followers 32
Posts 483
Boards Moderated 0
Alias Born 01/08/2008

Re: Fred Kadiddlehopper post# 251832

Thursday, 05/16/2024 12:17:36 PM

Thursday, May 16, 2024 12:17:36 PM

Post# of 252582
The CT-388 study was a 24 week study so I would think an effect from GI tolerability would be lessened although it could have had a very small impact. Just no way of telling in any case because Roche RHHBY didn't release any detailed tolerability data.

"People are best convinced by reasons they discover themselves"

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.